Post-covid state of external respiratory function in hospitalized and outpatient patients
https://doi.org/10.25789/YMJ.2022.78.19
Abstract
A study of the respiratory function was conducted in patients who recovered from COVID-19 from 3 to 12 months ago. The appearance of symptoms and disturbances of the respiratory function in the post-covid period did not have significant differences in hospitalized and outpatients, and were not associated with the severity of lung damage in the acute period of the disease, with the post-COVID period, smoking and the presence of respiratory chronic diseases. Obstructive and restrictive types of respiratory disorders were more often observed in female outpatients with post-traumatic disorders, that require rehabilitation measures in order to eliminate multiple organ complications.
About the Authors
L. D. Olesova
Yakut Scientific Center for Complex Medical Problems
Russian Federation
Russian Federation
Olesova Lyubov Dygynovna – Ph.D., leading researcher of the laboratories,
V. A. Makarova
Yakut Scientific Center for Complex Medical Problems
Russian Federation
Russian Federation
Makarova Victoria Alekseevna – therapist
M. A. Varlamova
Yakut Scientific Center for Complex Medical Problems
Russian Federation
Russian Federation
Varlamova Victoria Alekseevna – therapist; VARLAMOVA Maria Alekseevna – neurologist
S. I. Sofronova
Yakut Scientific Center for Complex Medical Problems
Russian Federation
Russian Federation
Sofronova Sargylana Ivanovna – Candidate of Medical Sciences, head of the department
E. N. Afanasyeva
Yakut Scientific Center for Complex Medical Problems
Russian Federation
Russian Federation
Afanasyeva Elena Nikolaevna – nurse of the Clinic
A. N. Romanova
Yakut Scientific Center for Complex Medical Problems
Russian Federation
Russian Federation
Romanova Anna Nikolaevna – Doctor of Medical Sciences, Director
References
1. Bulanov A.Yu. New coronavirus infection, hemostasis system and heparin dosing problems: it is important to say now / A.Yu. Bulanov, E.V. Roitman // Thrombosis, hemostasis and rheology. - 2020. - No. 2. – P. 11–18.
2. Possible approaches to the treatment of asthenic and cognitive impairments in post-covid syndrome / A.N. Bogolepova, N.A. Osinovskaya, E.A. Kovalenko, E.V. Makhnovich // Neurology, neuropsychiatry, psychosomatics. - 2021. - V.13, No. 4. - P.88-93.
3. International Statistical Classification of Diseases and Related Health Problems (10th revision) (ICD-10) (version dated April 27, 2021) 2.18/27-04-2021 Ministry of Health of the Russian Federation / Authorized organization. RS FGBU "TsNIIOIZ" of the Ministry of Health of Russia.
4. Mosolov S.N. Long-term mental disorders after acute coronavirus infection SARS-COV-2 / S.N. Mosolov // Modern therapy of mental disorders. -2021. - No. 3.-C.2-23.
5. Long-term symptoms of COVID-19 in residents of Yakutsk / L.D. Olesova, V.A. Makarova, A.I. Yakovleva, A.Yu. Nikolaev, A.N. Romanova // Yakut Medical Journal. 2021. No. 3 (75). pp. 66-69.
6. Post-covid syndrome of chronic fatigue and emotional disorders in residents of Yakutsk / M.A. Varlamov, T.K. Davydova, L.D. Olesova, V.A. Makarova // Yakut Medical Journal. 2021. No. 4 (76). - S. 86-89.
7. Choi E.D. "Long covid" (post-covid syndrome). The mechanism of occurrence, diagnosis and rehabilitation. Medical advice. 2021;(21-1):156–164.
8. Ali R.M.M., Ghonimy M.B.I. Post-COVID-19 pneumonia lung fibrosis: a worrisome sequelae in surviving patients. Egypt J Radiol Nucl Med 52, 101 (2021). DOI: 10.1186/s43055-021-00484-3
9. Bell M.L., Catalfamo C.J., Farland L.V. Postacute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLoS One. 2021;16. DOI: 10.1371/journal.pone.0254347.
10. Chaolin Huang et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 16-22 January; 397(10270): 220–232. Published online 2021 Jan 8. doi: 10.1016/S0140-6736(20)32656-8
11. Chopra V., Flanders S.A., O'Malley M., Malani A.N., Prescott H.C. Sixty-day outcomes among patients hospitalized with COVID-19. Ann. Intern. Med. 2021;174:576–578. DOI: 10.7326/M20-5661.
12. Davis HE, Assaf GS, McCorkell L et al. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact medRxiv preprint. DOI: 10.1101/2020.12.24.20248802; this version posted April 5, 2021. Available from: https://www.medrxiv.org/con-tent/10.1101/2020.12.24.20248802v3
13. Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery/Xiquan Yan, Huxiang Huang, Changfeng Wang, Yong Zeng, Xiaotong Han,Yimin Zhu// Letter to the editor. Volume 83, issue 3, p. 381-412, september 01, 2021. DOI: 10.1016/j.jinf.2021.05.034
14. Halpin SJ, McIvor C, Whyatt EG, et al. Post-discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93:1013-22. DOI: 10.1002/jmv.26368
15. Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271–80 e8. DOI: 10.1016/j.cell.2020.02.052
16. Jingjing You, Lu Zhang, Ma-yi-di-li Ni-jia-Ti, Jue Zhang,c Fuyin Hu, Luyan Chen,a Yuhao Dong, Ke Yang,b Bin Zhang, Shuixing Zhanga. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge. J Infect. 2020 Aug; 81(2): e150–e152. Published online 2020 Jun 5. DOI: 10.1016/j.jinf.2020.06.003
17. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programmeElina Larissa Petersen,1,2 Alina Goßling,1,2 Gerhard Adam et al./ Eur Heart J. 2022 Jan 6 : ehab914.Published online 2022 Jan 6. DOI: 10.1093/eurheartj/ehab914
18. Nalbandian A., Sehgal K., Gupta A. et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601–615. DOI: 10.1038/s41591-021-01283-z.
19. Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front Immunol. (2021) 12:686029. DOI: 10.3389/fimmu.2021.686029
20. Scullen T, Keen J, Mathkour M, et al. Coronavirus 2019 (COVID-19) – Associated Encephalopathies and Cerebrovascular Disease: The New Orleans Experience. World Neurosurg. 2020;141:e437-e446. DOI: 10.1016/j.wneu.2020.05.192.
21. Symptoms, complications and management of long COVID: a review. Olalekan Lee Aiyegbusi, Sarah E Hughes, Grace Turner, Samantha Cruz Rivera, Christel McMullan, Joht Singh Chandan,1 Shamil Haroon, Gary Price, Elin Haf Davies, Krishnarajah Nirantharakumar, Elizabeth Sapey, Melanie J Calvert, JR Soc Med. 2021 сен; 114(9): 428–442. Опубликовано в сети 15 июля 2021 г. DOI: 10.1177/01410768211032850.
22. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. (2020) 395:1417-8. DOI: 10.1016/S0140-6736(20)30937-5.
23. Yashavantha Rao HC, Jayabaskaran C. The emergence of a novel coronavirus (SARSCoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients. J Med Virol. 2020;92(7):786-790. https://doi.org/10.1002/jmv.25918.
Review
For citations:
Olesova L.D., Makarova V.A., Varlamova M.A., Sofronova S.I., Afanasyeva E.N., Romanova A.N. Post-covid state of external respiratory function in hospitalized and outpatient patients. Yakut Medical Journal. 2022;(2):71-76. https://doi.org/10.25789/YMJ.2022.78.19
Views:
29
Email this article 